“Glycolytic ATP production declines with age, contributing to common aging phenotypes such as reduced cell division and impaired DNA & mitochondria repair.”
Aging has long been attributed to a range of biological processes, including DNA damage, telomere shortening, and mitochondrial dysfunction. Yet, these frameworks often describe downstream consequences rather than a single unifying cause. Despite decades of research, a central question remains unresolved: what ultimately determines lifespan across species? Increasing attention has turned to cellular energy metabolism—particularly pathways responsible for rapid ATP generation—as a potential key driver. Understanding how these metabolic changes unfold over time, and how they influence survival, regeneration, and disease, remains a major challenge in aging biology.
A new research perspective published in Volume 18 of Aging-US introduces a unifying concept in aging biology, titled “A decline in glycolytic ATP production is the fundamental mechanism limiting lifespan; species with an optimal rate of decline over time survived.”
The study was led by first and corresponding author Akihiko Taguchi and co-author Yuka Okinaka, both from the Department of Regenerative Medicine Research, Foundation for Biomedical Research and Innovation at Kobe, Hyogo, Japan, in collaboration with Carsten Claussen and Sheraz Gul from the Fraunhofer Institute for Translational Medicine and Pharmacology, Hamburg, Germany.
A New Concept in Aging Biology
Rather than viewing aging as the result of accumulated damage alone, the authors propose that a gradual decline in glycolytic ATP production represents a central mechanism underlying aging across species. Glycolysis plays a critical role in supporting rapid energy demands, cell division, DNA repair, and mitochondrial maintenance. A reduction in this pathway over time may therefore contribute directly to many of the functional declines observed with aging.
An Evolutionary Perspective on Lifespan
The authors put forward a simple but compelling hypothesis: species that evolved with an optimal rate of decline in glycolytic ATP production were more likely to survive through natural selection.
In environments with limited food resources, increased energy efficiency—achieved through a shift toward oxidative metabolism—may provide a survival advantage. While this adaptation may benefit the species as a whole, it may also come at the cost of reduced cellular repair capacity and regenerative potential over time.
Linking Metabolism to Aging Phenotypes
Glycolytic ATP production is approximately 100 times faster than oxidative phosphorylation and is essential for high-demand cellular processes. Its decline with age is associated with impaired tissue repair, reduced cellular turnover, and increased vulnerability to stress. In contrast, cells that maintain high glycolytic activity—such as cancer cells—exhibit sustained proliferation and extended survival, highlighting the central role of metabolism in determining cellular lifespan.
Explaining Differences in Lifespan Across Species
Taken together, this framework may help explain several longstanding observations, including the wide variation in lifespan among species, the absence of biological immortality in most organisms, and the exceptional longevity of certain species such as the naked mole rat. According to the authors, differences in the rate of glycolytic decline may underlie these biological distinctions.
Implications for Aging and Disease
The authors also point to links between reduced glycolytic activity and age-related conditions, including neurodegenerative diseases, chronic kidney disease, and sarcopenia. Evidence from experimental and clinical studies suggests that enhancing glycolysis may help preserve cellular function and slow disease progression, supporting the relevance of this metabolic framework.
Future Directions
While the study is largely conceptual, it opens new directions for research into aging and longevity. Targeting glycolytic pathways—through metabolic, genetic, or cell-based approaches—may represent a promising strategy for promoting healthy aging. Further studies will be required to determine how these insights can be translated into safe and effective therapeutic interventions.
Conclusion
This study proposes a shift in how aging is understood, positioning the decline in glycolytic ATP production as a fundamental determinant of lifespan shaped by evolutionary pressures. By integrating metabolism, evolution, and cellular biology, the authors provide a cohesive framework that may guide future research and therapeutic development in aging science.
Click here to read the full research perspective published in Aging-US.
___
Aging-US is indexed by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed Central, Web of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).
Click here to subscribe to Aging-US publication updates.
For media inquiries, please contact [email protected].
